EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start?

Minh-Vu H Nguyen, Charles L Daley

Clinics in Chest Medicine · 2023-12 · 44 (4) · 771-783

DOI: 10.1016/j.ccm.2023.06.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Chest Medicine, 2023-12. Verfasst von Minh-Vu H Nguyen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, CO 80206, USA. Hauptthemen laut MEDLINE: Mycobacterium avium-intracellulare Infection, Lung Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 102 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of M avium pulmonary disease requires a three-drug, macrolide-based regimen that is administered for 12 months beyond culture conversion. The regimen can be administered 3 days a week in non-cavitary, nodular bronchiectatic disease but should be given daily when cavitary disease is present. For treatment refractory disease, amikacin liposome inhalation suspension is added to the regimen. Parenteral amikacin or streptomycin should be administered in the setting of extensive radiographic involvement or macrolide resistance. Recurrence of disease is common and often due to reinfection. Novel and repurposed agents are being evaluated in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium avium-intracellulare InfectionLung DiseasesHumansMycobacterium avium ComplexAnti-Bacterial AgentsAmikacinMacrolidesTreatment OutcomeDrug Resistance, Bacterial

Stichwörter der Autor:innen

AmikacinAzithromycinMacrolide-resistanceMycobacterium avium complexNontuberculous mycobacteria

Substanzen

Anti-Bacterial AgentsAmikacinMacrolides

Autor:innen und Institutionen

  • Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, CO 80206, USA.
  • Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, CO 80206, USA. Electronic address: daleyc@njhealth.org.

Zitieren

APA

Nguyen, M. H., & Daley, C. L. (2023). Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start?. Clinics in Chest Medicine, 44(4), 771-783. https://doi.org/10.1016/j.ccm.2023.06.009

Vancouver

Nguyen MH, Daley CL. Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start?. Clinics in Chest Medicine. 2023;44(4):771-783. doi:10.1016/j.ccm.2023.06.009

BibTeX
@article{Nguyen2023,
  author = {Nguyen, Minh-Vu H and Daley, Charles L},
  title = {Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start?},
  journal = {Clinics in Chest Medicine},
  year = {2023},
  volume = {44},
  number = {4},
  pages = {771--783},
  doi = {10.1016/j.ccm.2023.06.009}
}
Kostenlos starten →